124 related articles for article (PubMed ID: 23002042)
1. Glatiramer acetate ameliorates inflammatory bowel disease in mice through the induction of Qa-1-restricted CD8⁺ regulatory cells.
Yao Y; Han W; Liang J; Ji J; Wang J; Cantor H; Lu L
Eur J Immunol; 2013 Jan; 43(1):125-36. PubMed ID: 23002042
[TBL] [Abstract][Full Text] [Related]
2. The therapeutic effect of glatiramer acetate in a murine model of inflammatory bowel disease is mediated by anti-inflammatory T-cells.
Aharoni R; Sonego H; Brenner O; Eilam R; Arnon R
Immunol Lett; 2007 Oct; 112(2):110-9. PubMed ID: 17719654
[TBL] [Abstract][Full Text] [Related]
3. The effects of Foxp3-expressing regulatory T cells expanded with CD28 superagonist antibody in DSS-induced mice colitis.
Chen J; Xie L; Toyama S; Hünig T; Takahara S; Li XK; Zhong L
Int Immunopharmacol; 2011 May; 11(5):610-7. PubMed ID: 21163250
[TBL] [Abstract][Full Text] [Related]
4. CD8+CD122+ regulatory T cells (Tregs) and CD4+ Tregs cooperatively prevent and cure CD4+ cell-induced colitis.
Endharti AT; Okuno Y; Shi Z; Misawa N; Toyokuni S; Ito M; Isobe K; Suzuki H
J Immunol; 2011 Jan; 186(1):41-52. PubMed ID: 21098236
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effect of glatiramer acetate treatment on syndecan-1 expression in dextran sodium sulfate colitis.
Yablecovitch D; Shabat-Simon M; Aharoni R; Eilam R; Brenner O; Arnon R
J Pharmacol Exp Ther; 2011 May; 337(2):391-9. PubMed ID: 21310817
[TBL] [Abstract][Full Text] [Related]
6. Control of T cell reactivation by regulatory Qa-1-restricted CD8+ T cells.
Varthaman A; Khallou-Laschet J; Clement M; Fornasa G; Kim HJ; Gaston AT; Dussiot M; Caligiuri G; Herbelin A; Kaveri S; Cantor H; Nicoletti A
J Immunol; 2010 Jun; 184(12):6585-91. PubMed ID: 20488793
[TBL] [Abstract][Full Text] [Related]
7. Implication for the CD94/NKG2A-Qa-1 system in the generation and function of ocular-induced splenic CD8+ regulatory T cells.
Chattopadhyay S; O'Rourke J; Cone RE
Int Immunol; 2008 Apr; 20(4):509-16. PubMed ID: 18359787
[TBL] [Abstract][Full Text] [Related]
8. Orally administered lactoperoxidase ameliorates dextran sulfate sodium-induced colitis in mice by up-regulating colonic interleukin-10 and maintaining peripheral regulatory T cells.
Shin K; Horigome A; Yamauchi K; Yaeshima T; Iwatsuki K
Int Immunopharmacol; 2009 Nov; 9(12):1387-93. PubMed ID: 19723594
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic SCT modulates gut inflammation in experimental inflammatory bowel disease.
Godoi DF; Cardoso CR; Ferraz DB; Provinciatto PR; Cunha FQ; Silva JS; Voltarelli JC
Bone Marrow Transplant; 2010 Oct; 45(10):1562-71. PubMed ID: 20228850
[TBL] [Abstract][Full Text] [Related]
10. Aggravation of intestinal inflammation by depletion/deficiency of gammadelta T cells in different types of IBD animal models.
Kühl AA; Pawlowski NN; Grollich K; Loddenkemper C; Zeitz M; Hoffmann JC
J Leukoc Biol; 2007 Jan; 81(1):168-75. PubMed ID: 17041003
[TBL] [Abstract][Full Text] [Related]
11. T cell responses to bluetongue virus are directed against multiple and identical CD4+ and CD8+ T cell epitopes from the VP7 core protein in mouse and sheep.
Rojas JM; Rodríguez-Calvo T; Peña L; Sevilla N
Vaccine; 2011 Sep; 29(40):6848-57. PubMed ID: 21807057
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory therapeutic effect of glatiramer acetate on several murine models of inflammatory bowel disease.
Aharoni R; Kayhan B; Brenner O; Domev H; Labunskay G; Arnon R
J Pharmacol Exp Ther; 2006 Jul; 318(1):68-78. PubMed ID: 16624971
[TBL] [Abstract][Full Text] [Related]
13. The therapeutic effect of TV-5010 in a murine model of inflammatory bowel disease -- Dextran induced colitis.
Aharoni R; Brenner O; Cohen A; Arnon R
Int Immunopharmacol; 2008 Nov; 8(11):1578-88. PubMed ID: 18664394
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor β activation ameliorates DSS-induced chronic colitis by inhibiting inflammation and promoting Treg differentiation.
Guo D; Liu X; Zeng C; Cheng L; Song G; Hou X; Zhu L; Zou K
Int Immunopharmacol; 2019 Dec; 77():105971. PubMed ID: 31678865
[TBL] [Abstract][Full Text] [Related]
15. Blockade of CXCL12/CXCR4 axis ameliorates murine experimental colitis.
Mikami S; Nakase H; Yamamoto S; Takeda Y; Yoshino T; Kasahara K; Ueno S; Uza N; Oishi S; Fujii N; Nagasawa T; Chiba T
J Pharmacol Exp Ther; 2008 Nov; 327(2):383-92. PubMed ID: 18716065
[TBL] [Abstract][Full Text] [Related]
16. Evidence that CD4+, but not CD8+ T cells are responsible for murine interleukin-2-deficient colitis.
Simpson SJ; Mizoguchi E; Allen D; Bhan AK; Terhorst C
Eur J Immunol; 1995 Sep; 25(9):2618-25. PubMed ID: 7589135
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic induction of regulatory, cytotoxic CD8+ T cells in multiple sclerosis.
Tennakoon DK; Mehta RS; Ortega SB; Bhoj V; Racke MK; Karandikar NJ
J Immunol; 2006 Jun; 176(11):7119-29. PubMed ID: 16709875
[TBL] [Abstract][Full Text] [Related]
18. Perforin deficiency attenuates inflammation and tumor growth in colitis-associated cancer.
Waldner MJ; Wirtz S; Becker C; Seidel D; Tubbe I; Cappel K; Hähnel PS; Galle PR; Schuler M; Neurath MF
Inflamm Bowel Dis; 2010 Apr; 16(4):559-67. PubMed ID: 19785028
[TBL] [Abstract][Full Text] [Related]
19. Regulatory dendritic cells pulsed with carbonic anhydrase I protect mice from colitis induced by CD4+CD25- T cells.
Yamanishi H; Murakami H; Ikeda Y; Abe M; Kumagi T; Hiasa Y; Matsuura B; Onji M
J Immunol; 2012 Mar; 188(5):2164-72. PubMed ID: 22291189
[TBL] [Abstract][Full Text] [Related]
20. Perforin-dependent cytotoxic activity and lymphokine secretion by CD4+ T cells are regulated by CD8+ T cells.
Williams NS; Engelhard VH
J Immunol; 1997 Sep; 159(5):2091-9. PubMed ID: 9278294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
